2:44 am On The Wires (:WIRES) :

• Jazz Pharmaceuticals (JAZZ) announced the results of its tender offer to purchase all of the outstanding shares of common stock of Celator Pharmaceuticals (CPXX) at $30.25 per share, net to the seller in cash, without interest (less any required withholding taxes). The tender offer is being effected by Jazz Pharmaceuticals' indirect wholly-owned subsidiary, Plex Merger Sub
• Accenture (ACN) has opened an Accenture Digital Hub in Tokyo, Japan to support the digital transformation of clients by helping them embrace open innovation.
• Spirit AeroSystems (SPR) announced it is installing one of the world's largest autoclaves at its Wichita, Kan., facility to support increasing production levels in the company's composite fuselage business and to grow overall composite production capability. 
• Cellcom Israel (CEL) announced that the Company entered a 4G network sharing and 2G and 3G hosting services agreement, with Marathon 018 Xfone, or Xfone, which was awarded 4G frequencies in the 2015 frequencies tender and hasn't entered the cellular market yet.

2:39 am Delhaize Group and Ahold (AHONY) provides update on merger; expects completion before the end of July; Ahold provides details on its 1 bln capital repayment (DEG) :

Delhaize Group (DEG) and Ahold (AHONY) have confirmed that they expect the merger to complete before the end of July, subject to regulatory approval by the Federal Trade Commission of the United States.

• In addition, Ahold provided further details on its 1 billion capital repayment and reverse stock split, which had been announced on June 24, 2015 and approved by Ahold's shareholders on March 14, 2016.
• The capital repayment and reverse stock split are expected to take place after close of New York Stock Exchange trading hours on July 15, 2016 by way of a consolidation of every 17 issued Ahold common shares into 16 common shares and a capital repayment of 1.29 per remaining share (equivalent to about 1.21 per old share).

2:28 am Peugeot reports H1 consolidated sales in Europe rose 7.4% year-on-year to 1,056,000 units (PEUGF) :

Co reports sales climbed 7.9% to 601,000 units, led mainly by the Peugeot 2008 (up 16%, or 99,900 units) and Partner (up 8%, or 62,800 units), which were both ranked no. 2 in their respective segments in Europe.

• The 208 and 308 models continued to advance, up 15% (157,800 units) and 10% (119,200 units), respectively. Sales of the brand were particularly impressive in Italy (up 17.4%), Spain (up 12.5%) and the Netherlands (up 8.8%).
• Citron delivered its best sales performance for five years, advancing 7.2% to 414,000 units.
• China & Southeast Asia market, PSA Group sales were down 19.4% to 297,000 units.

2:07 am AEGON provides update on UK annuity book divestments; will incur a post-tax book loss of GBP481 mln, up from the GBP245 mln previously indicated (AEG) :

Co confirms that the disposals are proceeding as planned, with the market and underwriting risks transferred to the counter parties.

• In line with our earlier communicated estimates this will lead to a total capital release of GBP500 mln once both transactions have been finalized through the Part VII transfers, which are expected to be completed in the first half of 2017. The Rothesay Life and the Legal & General transactions each contributed 15% to Aegon UK's Solvency II ratio based on year-end 2015 and March 31, 2016 capital positions, respectively. Whereas the absolute amount of the capital release is unchanged, the relative impact on the Solvency II ratio in the second quarter amounts to ~20% combined, mainly as a result of market-driven higher capital requirements.
• In finalizing the transaction agreements and as part of its quarterly closing process, Aegon has adjusted the IFRS book loss on these transactions.
  • In its second quarter 2016 results, Aegon will incur a post-tax book loss of GBP481 mln (EUR618 mln), up from the GBP245 mln (EUR315 mln) previously indicated. This loss is expected to be partly offset by the release of the expense reserves on the annuity portfolio of GBP70 mln (EUR82 mln) post tax upon completion of the Part VII transfers.
  • In addition, Aegon expects to realize gains on assets that are to be disposed of and were related to the annuity book with an unrealized gain position of GBP50 mln (EUR59 mln) post tax at May 31, 2016.

1:41 am On The Wires (:WIRES) :

• IBM (IBM) announced plans to establish the first IBM Center for Blockchain Innovation in Singapore. In the first collaboration of its kind with the Singapore Economic Development Board and the Monetary Authority of Singapore, IBM Researchers will work with government, industries and academia to develop applications and solutions which are based on enterprise blockchain, cyber-security, and cognitive computing technologies.
• Orange (ORAN) announced it is now offering the Samsung (SSNLF) Gear S2 Classic 3G smartwatch, with the recommended Multi-SIM Calls & Internet option.
• NI (NATI), the provider of platform-based systems that enable engineers and scientists to solve the world's greatest engineering challenges, today announced a second-generation vector signal transceiver
• ORIX Real Estate Corporation, a subsidiary of ORIX (IX), and Okura Nikko Hotel Management, operator of the Hotel JAL City brand, jointly announced that this coming September they will open Hotel JAL City Haneda Tokyo West Wing as the brand's second hotel near Tokyo's Haneda International Airport. ORIX Real Estate will operate the hotel, which is currently being constructed by Airport Facilities Co
• CAE (CAE) announced the launch of the validation phase of its Next Generation Training System with its longstanding partner AirAsia.
  

1:37 am Barnes Group acquires Adval Tech Holding's molds business for ~$136 mln (B) :

Co announced that it has entered into a definitive agreement to acquire Adval Tech's molds business, focused on the development and manufacture of complex plastic injection molds for packaging, medical, consumer, and automotive applications. FOBOHA, which is headquartered in Haslach, Germany, operates out of three manufacturing locations in Germany, Switzerland, and China.

• Barnes Group has agreed to purchase the FOBOHA mold-making business for CHF 133 million (~$136 million), subject to certain closing adjustments, and is expected to finance the transaction with cash on hand and borrowings under the Company's revolving credit facility.
• The acquisition is expected to close in the third quarter of 2016

1:29 am Grana y Montero signs an addendum to the Concession Contract which will improve the system capacity with the acquisition of trains, railcars and complementary works for an amount of $410 mln (GRAM) :

• According to the manufacturer's schedule, the first two trains will arrive by the end of 2017, whilst others will arrive at the beginning of 2018. Therefore, the frequency of each passing train could be reduced to 5 minutes.
• During 2018, more units will continue to arrive, while the last ones will arrive by the end of that same year.

1:27 am Ecopetrol Board approves the establishment of companies for the purpose of continuing to execute the strategy of Ecopetrol Business Group for 2020 (EC) :

Co reports that its Board of Directors has approved the establishment of the following companies for the purpose of continuing to execute the strategy of Ecopetrol Business Group for 2020:

• A Colombian company, 100% indirectly owned by Ecopetrol S.A. through Propilco S.A., to which the indirect participations that Ecopetrol S.A. currently has in Comai Ltda. and in Sociedad Portuaria de Oleofinas y Derivados will be transferred.
• A foreign company domiciled in Peru, 100% indirectly owned by Ecopetrol S.A., which will be directly affiliated with Propilco S.A. and will serve the Peruvian market directly.
• A Colombian company, 100% directly owned by Ecopetrol S.A., for the purpose of contributing a participation of 43.35% and the litigation rights that the Company currently possesses in Inversiones de Gases de Colombia S.A., derived from an ordinary legal proceeding currently in progress in the Civil Cassation Court of the Supreme Court of Justice, in which Ecopetrol S.A. and other companies are acting as plaintiffs.

1:25 am Ballard Power signed a definitive agreement with Guangdong Nation Synergy Hydrogen Power Technology for a Technology Solutions transaction (BLDP) :

Co announced that it has signed a definitive agreement with Guangdong Nation Synergy Hydrogen Power Technology Co for a Technology Solutions transaction to enable Synergy to exclusively manufacture and sell Ballard's direct hydrogen FCgen-H2PM fuel cell backup power systems in China.

• Ballard will license the designs of its 1.7 and 5 kilowatt FCgen-H2PM systems to Synergy for manufacture in the City of Yunfu in Guangdong Province and exclusive sales in China.
• Synergy has paid Ballard an upfront Technology Solutions fee of $2.5 million for the license and related technology services and will make additional recurring payments to Ballard for each unit sold, subject to annual minimums.
• Ballard will also be the exclusive supplier of air-cooled fuel cell stacks to Synergy for use in the FCgen-H2PM systems that it produces and sells.

1:22 am Stifel Financial prices offering of $150 mln perpetual 6.25% Non-Cumulative Perpetual Preferred Stock, Series A and $200 mln principal amount of the Company's 4.25% Senior Notes due 2024 (SF) :  

1:20 am Pan Am Silver and Maverix Metals announce they have completed a statutory plan of arrangement (PAAS) :

• Pursuant to the Arrangement, the Company acquired 42,850,000 common shares of Maverix for consideration of CAD$52,823,048 ($40,240,000), based on the Bank of Canada noon exchange rate of 1.3127 on July 11, 2016, representing payment by the Company of ~CAD$1.23 per Common Share, and 20,000,000 common share purchase warrants for consideration of CAD$2,625,400 ($2,000,000), based on the Bank of Canada noon exchange rate of 1.3127 on July 11, 2016, representing cash consideration by the Company of ~CAD$0.13 per Warrant.
• The Warrants are exercisable for five years, with one-half exercisable at CAD$0.70 ($0.564) per share and the other half exercisable for CAD$1.00 ($0.78) per share.
• Immediately following the Arrangement, Pan American directly owned 42,850,000 Common Shares and 20,000,000 Warrants, representing approximately fifty four percent (54%) of the total number of the issued and outstanding common shares of Maverix on a non-diluted basis, and approximately sixty three percent (63%) of the issued and outstanding shares on a fully-dilued basis.
• The Company's acquisition was made for investment purposes. The Company may, in the future, acquire ownership and control over additional securities of Maverix for investment purposes.
  

1:16 am Pan Am Silver files base shelf prospectus and registration statement to make offerings of common shares, debt securities, subscription receipts, units, warrants, or any combination thereof of up to $500 mln (PAAS) :  

1:14 am Regency Centers prices 4,350,000 shares of its common stock, which will result in ~$353 mln of gross proceeds (REG) :  

1:13 am Shire receives FDA approval for Xiidra (SHPG) :

Co announces that the FDA has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.

• Xiidra is the only prescription eye drop indicated for the treatment of both signs and symptoms of this condition.
• In all four studies, a larger reduction in EDS was observed with Xiidra at six and 12 weeks. In two of the four studies, an improvement in EDS was seen with Xiidra at two weeks.
• At week 12, a larger reduction in ICSS favoring Xiidra was observed in three of the four studies. The most common adverse reactions reported in 5 to 25 percent of patients were instillation site irritation, altered taste sensation (dysgeusia) and reduced visual acuity.
• Shire expects to launch Xiidra in the United States in the third quarter of 2016.